October 2018

The position: ETAP-Lab invites applications for an exciting young researcher permanent position in research and development of a new models in neurodegenerative disease. The successful candidate will work in a collaborative research environment with academical interactions. The first two years, the candidate will be dedicated to the project BIOPROLOR2*; it is a public-private consortium which aims at discovering new plant-derived molecules with health benefits to speed up the development of innovative drugs and active ingredients. ETAP-Lab leads the strategic axis of

  New ETAP-Lab studies on TEMISIS' drug candidate TEM1657 for Psoriasis   ETAP-Lab performed new studies for the account of TEMISIS on a mouse imiquimod-induced psoriasis model. The output of these studies showed that TEM1657 brings remarkable effects on psoriasis: Higher efficacy compared to the reference molecule No side effects Oral administration, which is new for the psoriasis treatment The French biotech company “Temesis”, subsidiary of Plant Advanced Technologies, recently published a new press release to announce these new promising preclinical results on psoriasis with